Motif Bio Ord 1p Share Price (MTFB)

7.05 -0.30 (-4.08%) delayed: 10:09AM GMT
Bid price 7.00 Open price 7.30
Ask price 7.10 Prev close 7.35
High price 7.46 Spread 1.41%
Low price 6.88 Volume 2,243,942

Register now for FREE live Motif Bio Ord 1p share prices, Motif Bio Ord 1p stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Motif Bio Ord 1p Level 2 Data, indepth research tools and investor commentary for Motif Bio Ord 1p (MTFB) and other London Stock Exchange equities.

Motif Bio Ord 1p Share Price Chart

Advanced Charts >>

Register now for FREE Motif Bio Ord 1p share price charts

Motif Bio Ord 1p Share Price Information

Name Motif Bio Ord 1p Epic MTFB
Sector Pharmaceuticals & Biotechnology ISIN GB00BVVT4H71
Activites Motif Bio plc is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics designed to be effective against serious and life-threatening infections in hospitalised patients caused by multi-drug resistant bacteria, including MRSA. The Company's lead product candidate, iclaprim, is being developed for high-risk MRSA patient populations. The first proposed indication, and near-term commercial opportunity, is for the treatment of acute bacterial skin and skin structure infections (ABSSSI), one of the most common bacterial infections, with 3.6 million patients hospitalised annually in the US. The Company believes that iclaprim may be suitable for first-line empiric therapy in ABSSSI patients, especially those with renal impairment, with or without diabetes. Unlike current standard of care antibiotics, in clinical trials to date, nephrotoxicity has not been observed with iclaprim and dosage adjustment has not been required in patients with renal impairment. Index n/a

Motif Bio Ord 1p Key Numbers

Latest Share Price (p) 7.05 Net Gearing (%) 52.92
Market Capitalisation (£m) 21.69 Gross Gearing (%) 130.52
Shares in issue (m) 297.49 Debt Ratio 272.24
P/E Ratio -0.38 Debt-to-Equity Ratio 0.37
Total dividends per share (p) 0.00 Assets / Equity Ratio -3.28
Dividend Yield (%) 0.00 Price to book value -2.43
Dividend cover (x) 0.00 ROCE (%) -866.34
Earning per share (p) -19.00 EPS Growth (%) 45.71
52 week high / low 44.90 / 4.75 DPS Growth (%) n/a

Motif Bio Ord 1p Director Deals

Dec.Date Type Director Pos No. of Shares
05/10/2015 BUY John Stakes RES 100,000

More Motif Bio Ord 1p Director Deals >>

Motif Bio Ord 1p Company News

07:00 19/02/2019

Conference Call and Webcast

RNS Number : 4139Q Motif Bio PLC 19 February 2019     Motif Bio plc ("Motif Bio" or the "Company")   Motif Bio Conference Call and Webcast   Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics,...

08:32 18/02/2019

Motif Bio to raise capital after making early debt repayment

Antibiotic developer Motif Bio said it would need to raise capital after it made an early debt repayment to Hercules Capital. The company said it would make an immediate early repayment of $7m and a further repayment of $0.5m on the earlier of 90 days, being 18 May 2019, or receipt of funds from...

07:00 18/02/2019

Amendment Agreement with Hercules Capital

RNS Number : 3265Q Motif Bio PLC 18 February 2019     The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via...

More Motif Bio Ord 1p Company News >>

Register now for FREE Motif Bio Ord 1p company news

Motif Bio Ord 1p Share Price Discussions

2 days ago

Motif Bio Plc (MTFB)

Motif is developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Motif has a lead antibiotic candidate, iclaprim, and MTF-001, a preclinical program to design a best-in-class dihydrofolate reductase...

Register now for FREE Motif Bio Ord 1p share price discussions